2009
DOI: 10.1080/15504260802628767
|View full text |Cite
|
Sign up to set email alerts
|

Atomoxetine Treatment for Cocaine Abuse and Adult Attention Deficit/Hyperactivity Disorder (ADHD): A Preliminary Open Trial

Abstract: The purpose of this 12-week open trial was to evaluate the potential utility of atomoxetine for the treatment of attention deficit hyperactivity disorder (ADHD) in cocaine-dependent treatment seekers. The sample consisted of 20 participants with all participants meeting DSM-IV-TR criteria for ADHD and cocaine dependence (CD). Using several measures to assess ADHD, there was a significant reduction in ADHD symptoms. There was no significant decrease in cocaine use throughout the trial. Taken together, although … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
26
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(27 citation statements)
references
References 36 publications
(51 reference statements)
1
26
0
Order By: Relevance
“…The lack of therapeutic effects solely by ATO in the present study is not uncommon, as ATO has shown mixed effects on decreasing stimulant use (Levin et al, 2009; Walsh et al, 2013; Rush et al, 2011). A previous study indicated that ATO alone decreased reinstatement (Zlebnik and Carroll, 2015), but Broos and colleagues (2015) showed no effect on reinstatement if rats had received extinction training.…”
Section: Discussionmentioning
confidence: 61%
See 1 more Smart Citation
“…The lack of therapeutic effects solely by ATO in the present study is not uncommon, as ATO has shown mixed effects on decreasing stimulant use (Levin et al, 2009; Walsh et al, 2013; Rush et al, 2011). A previous study indicated that ATO alone decreased reinstatement (Zlebnik and Carroll, 2015), but Broos and colleagues (2015) showed no effect on reinstatement if rats had received extinction training.…”
Section: Discussionmentioning
confidence: 61%
“…In humans, ATO decreased both physiological (e.g., blood pressure increases) and subjective (e.g., pleasurable ratings) responses to d-amphetamine (Sofouglu et al, 2009). However, in some studies, no effects of ATO on stimulant use have been found (Levin et al, 2009; Walsh et al, 2013; Rush et al, 2011). …”
Section: Introductionmentioning
confidence: 98%
“…However, ATO has other characteristics that make it a promising candidate. In animal models of drug abuse and relapse, ATO treatment alone (Economidou et al 2009; Economidou et al 2011) or in combination with other treatments reduced cue- and/or cocaine-primed cocaine seeking in male (Swalve et al 2016) and female (Zlebnik and Carroll 2014) rats, but did not reduce cocaine self-administration in humans (Economidou et al 2011; Levin et al 2009; Walsh et al 2013). Taken together, these studies suggest that ATO may be an effective treatment to reduce impulsive choice for cocaine for both sexes.…”
Section: Introductionmentioning
confidence: 99%
“…Using ATO, studies have demonstrated reduced impulsivity across a range of behavioral tasks such as the 5-choice serial reaction time (Baarendse and Vanderschuren 2012, Robinson et al 2008), stop-signal reaction time (Robinson et al 2008), and delay-discounting (Bizot et al 2011, Robinson et al 2008) tasks (but see Baarendse & Vanderschuren, 2012, Broos et al 2012, Sun et al 2012). Regarding atomoxetine’s effects on stimulant addiction, some clinical investigations have found no therapeutic effect on cocaine use (Levin et al 2009, Walsh et al 2013) and the subjective effects of methamphetamine (Rush et al 2011), while others found reduced physiological and subjective effects of d-amphetamine (Sofuoglu et al 2009), significant attenuation of alcohol cravings (Wilens et al 2011), longer abstinence from alcohol use (Benegal et al 2013), and fewer days of heavy alcohol drinking (Wilens et al 2008). Similarly equivocal findings were demonstrated in rodents.…”
Section: Introductionmentioning
confidence: 99%